Bisphosphonate use for the management of breast cancer patients with bone metastases: A survey of Canadian Medical Oncologists

被引：0
|
作者：
Sunil Verma
Danielle Kerr-Cresswell
George Dranitsaris
Flay Charbonneau
Maureen Trudeau
Geetha Yogendran
Anne-Marie Cesta
Mark Clemons
机构：
[1] Toronto Sunnybrook Regional Cancer Centre and Cancer Care Ontario,Division of Medical Oncology
[2] Toronto-Sunnybrook Regional Cancer Centre,undefined
来源：
Supportive Care in Cancer | 2004年 / 12卷
关键词：
Bisphosphonates; Guidelines; Drug-use evaluation; Breast cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：852 / 858
页数：6
相关论文
共 50 条
  • [21] ClodronateA Review of its Use in the Prevention of Bone Metastases and the Management of Skeletal Complications Associated with Bone Metastases in Patients with Breast Cancer
    Toni M. Dando
    Lynda R. Wiseman
    Drugs & Aging, 2004, 21 : 949 - 962
  • [22] Clodronate - A review of its use in the prevention of bone metastases and the management of skeletal complications associated with bone metastases in patients with breast cancer
    Dando, TM
    Wiseman, LR
    DRUGS & AGING, 2004, 21 (14) : 949 - 962
  • [23] LONG-TERM BONE MANAGEMENT BY BISPHOSPHONATE IN METASTATIC BREAST CANCER PATIENTS
    Watanabe, Junichiro
    Yonekura, Rika
    Hayashi, Tomomi
    Nishimura, Seiichiro
    Takahashi, Kaoru
    BREAST, 2013, 22 : S53 - S53
  • [24] Perceptions and attitudes of medical oncologists regarding fertility preservation and pregnancy in high-risk cancer patients: A survey among Canadian medical oncologists
    Alshamsan, Bader
    Kushnir, Igal
    Al-Saadi, Sulaiman
    Srikanthan, Amirrtha
    CANCER MEDICINE, 2023, 12 (02): : 1912 - 1921
  • [25] Adjuvant bisphosphonate use in patients with early stage breast cancer: a physician survey
    Sharon McGee
    Mashari Alzahrani
    Lisa Vandermeer
    Katherine Cole
    Gail Larocque
    Arif Awan
    Brian Hutton
    Gregory Pond
    Deanna Saunders
    Mark Clemons
    Breast Cancer Research and Treatment, 2021, 187 : 477 - 486
  • [26] Prevention of bone metastases from breast cancer by adjuvant bisphosphonate therapy
    Norio Kohno
    Ikuo Kokufu
    Breast Cancer, 2003, 10 (1) : 33 - 37
  • [27] Adjuvant bisphosphonate use in patients with early stage breast cancer: a physician survey
    McGee, Sharon
    Alzahrani, Mashari
    Vandermeer, Lisa
    Cole, Katherine
    Larocque, Gail
    Awan, Arif
    Hutton, Brian
    Pond, Gregory
    Saunders, Deanna
    Clemons, Mark
    BREAST CANCER RESEARCH AND TREATMENT, 2021, 187 (02) : 477 - 486
  • [28] Bone-Targeted Agents for the Management of Breast Cancer Patients with Bone Metastases
    Simos, Demetrios
    Addison, Christina L.
    Kuchuk, Iryna
    Hutton, Brian
    Mazzarello, Sasha
    Clemons, Mark
    JOURNAL OF CLINICAL MEDICINE, 2013, 2 (03) : 67 - 88
  • [29] Skeletal retention of bisphosphonate (pamidronate) and its relation to the rate of bone resorption in patients with breast cancer and bone metastases
    Cremers, SCLM
    Papapoulos, SE
    Gelderblom, H
    Seynaeve, C
    den Hartigh, J
    Vermeij, P
    van der Rijt, CCD
    van Zuylen, L
    JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 (09) : 1543 - 1547
  • [30] Effects of de-escalated bisphosphonate therapy on bone turnover biomarkers in breast cancer patients with bone metastases
    Addison, Christina L.
    Pond, Gregory R.
    Zhao, Huijun
    Mazzarello, Sasha
    Vandermeer, Lisa
    Goldstein, Robyn
    Amir, Eitan
    Clemons, Mark
    SPRINGERPLUS, 2014, 3
12345